Aduro BioTech, Inc. Gains 20.43%
Tue, Feb 04, 2020 at 05:30 PM
Aduro BioTech, Inc. (ADRO:NASDAQ) soared at $2.24, representing a gain of 20.4%. On Mon 03 Feb 20, ADRO:NASDAQ touched a New 2-Week High of $1.86. The stock got featured on our News Catalysts scanner on Tue 21 Jan 20 at 05:36 PM in the 'BIOTECH' category. From Mon 13 Jan 20, the stock recorded 71.43% Up Days and 66.67% Green Days
About Aduro BioTech, Inc. (ADRO:NASDAQ)
Aduro Biotech Inc is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies that transform the treatment of different diseases.
Top 10 Gainers:
- ContraFect Corporation (CFRX:NASDAQ), 968.49%
- Myomo, Inc. (MYO:NYSEMKT), 114.71%
- iBio, Inc. (IBIO:NYSEMKT), 61.69%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 36.84%
- Puma Biotechnology, Inc. (PBYI:NASDAQ), 31.59%
- Digital Ally, Inc. (DGLY:NASDAQ), 28.13%
- Allot Ltd. (ALLT:NASDAQ), 26.78%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 21.77%
- Aduro BioTech, Inc. (ADRO:NASDAQ), 20.43%
- Blink Charging Co. (BLNK:NASDAQ), 20.29%